Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

European Journal of Cancer

Volumn 38, Issue 17, 2002, Pages 2258-2264

  McKay, J A ^a   Murray, L J ^a   Curran, S ^a   Ross, V G ^a   Clark, C ^a   Murray, G I ^a   Cassidy, J ^a   McLeod, H L ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Epidermal growth factor receptor; Immunohistochemistry; Lymph node metastases; Polymorphism; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DISEASE ASSOCIATION; DNA POLYMORPHISM; EVALUATION; FEMALE; GENDER; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; COHORT STUDIES; COLORECTAL NEOPLASMS; DINUCLEOTIDE REPEATS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS;

EID: 0036849596     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00234-4     Document Type: Article

References (25)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
2. McLeod H.L., Murray G.I. Tumour markers of prognosis in colorectal cancer. Br. J. Cancer. 79:1999;191-203.
3. Zwick E., Hackel P.O., Prenzel N., Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 20:1999;408-412.
4. Alroy I., Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis. signal diversification through combinatorial ligand-receptor interactions FEBS Lett. 410:1997;83-86.
5. DiFiore P.P., Pierce J.H., Fleming T.P.et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell. 51:1987;1063-1070.
6. Nicholson S., Richard J., Sainsbury C.et al. Epidermal growth-factor receptor (EGFR) - results of a 6 year follow-up-study in operable breast cancer with emphasis on the node negative group. Br. J. Cancer. 63:1991;146-150.
7. Tateishi M., Ishida T., Mitsudomi T., Kaneko S., Sugimachi K. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the lung. Cancer Res. 50:1990;7077-7080.
8. Neal D.E., Sharples L., Smith K., Fennelly J., Hall R.R., Harris A.L. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer. 65:1990;1619-1625.
9. Klapper L.N., Kirschbaum M.H., Sela M., Yarden Y. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv. Cancer Res. 77:2000;25-79.
10. Mendelsohn J., Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 19:2000;6550-6565.
11. Ciardiello F., Tortora G. A novel approach in the treatment of cancer. targeting the epidermal growth factor receptor Clin. Cancer Res. 7:2001;2958-2970.
12. Baselga J. The EGFR as a target for anticancer therapy-focus on cetuximab. Eur. J. Cancer. 37 (Suppl. 4):2001;16-22.
13. Reissmann P.T., Koga H., Figlin R.A., Holmes E.C., Slamon D.J. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group. J. Cancer Res. Clin. Oncol. 125:1999;61-70.
14. Chi D.D., Hing A.V., Helms C., Steinbrueck T., Mishra S.K., Donis-Keller H. Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and proα2 (I) collagen (COL1A2). Hum. Mol. Genet. 1:1992;135.
15. Gebhardt F., Zanker K.S., Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J. Biol. Chem. 274:1999;13176-13180.
16. Buerger H., Gebhardt F., Schmidt H.et al. Length and loss of heterozygosity of an intron 1 polymorphic sequence of egfr is related to cytogenetic alterations and epithelial growth factor. Cancer Res. 60:2000;854-857.
17. McKay J.A., Douglas J.J., Ross V.G.et al. Analysis of key cell cycle checkpoint proteins in colorectal tumours. J. Pathol. 196:2002;386-393.
18. McKay J.A., Douglas J.J., Ross V.G.et al. Expression of cell cycle control proteins in primary colorectal tumors does not always predict protein expression in lymph node metastases. Clin. Cancer Res. 6:2000;113-118.
19. McKay J.A., Douglas J.J., Ross V.G.et al. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int. J. Cancer. 88:2000;77-81.
20. Mayer A., Takimoto M., Fritz E., Schellander G., Kofler K., Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer. 71:1993;2454-2460.
21. Radinsky R., Risin S., Fan D.et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res. 1:1995;19-31.
22. Shimada N., Suzuki J., Fujita J.et al. A comparative study of nucleolar organizer region, proliferating cell nuclear antigen and epidermal growth factor receptor staining in colon tumours. J. Gastroen. Hepatol. 13:1998;794-800.
23. McLeod H.L., McKay J.A., Collie-Duguid E.S.R., Cassidy J. Therapeutic opportunities from tumour biology in metastatic colon cancer. Eur. J. Cancer. 36:2000;1706-1712.
24. Yamauchi H., Stearns V., Hayes D.F. When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer. J Clin Oncol. 9:2001;2334-2356.
25. Bradley S.J., Garfinkle G., Walker E., Salem R., Chen L.B., Steele G. Increased expression of the epidermal growth factor receptor on human colon carcinoma cells. Arch. Surg. 121:1986;1242-1247.